1. Adelaide Research & Scholarship

Search


Current filters:



Start a new search
Add filters:

Use filters to refine the search results.

 | 
Results 1-10 of 10 (Search time: 0.002 seconds).
  • previous
  • 1
  • next
Item hits:
PreviewIssue DateTitleAuthor(s)
2014Gemcitabine and CHK1 inhibition potentiate EGFR-directed radioimmunotherapy against pancreatic ductal adenocarcinomaAl-Ejeh, F.; Pajic, M.; Shi, W.; Kalimutho, M.; Miranda, M.; Nagrial, A.; Chou, A.; Biankin, A.; Grimmond, S.; Brown, M.; Khanna, K.
2011Actomyosin contractililty: force power drives tumor growthSamuel, M.S.; Olson, M.F.
2015p84 forms a negative regulatory complex with p110γ to control PI3Kγ signalling during cell migrationTurvey, M.; Klingler-Hoffmann, M.; Hoffmann, P.; McColl, S.
2013Tropomyosin regulates cell migration during skin wound healingLees, J.; Ching, Y.; Adams, D.; Bach, C.; Samuel, M.; Kee, A.; Hardeman, E.; Gunning, P.; Cowin, A.; O'Neill, G.
2012Signalling pathways mediating specific synergistic interactions between GDF9 and BMP15Mottershead, D.; Ritter, L.; Gilchrist, R.
2011Pharmacological and genetic evaluation of proposed roles of mitogen-activated protein kinase/extracellular signal-regulated kinase kinase (MEK), extracellular signal-regulated kinase (ERK), and p90RSK in the control of mTORC1 proteinFonseca, B.; Alain, T.; Finestone, L.; Huang, B.; Rolfe, M.; Jiang, T.; Yao, Z.; Hernandez, G.; Bennett, C.; Proud, C.
2016GCN2 contributes to mTORC1 inhibition by leucine deprivation through an ATF4 independent mechanismAverous, J.; Lambert-Langlais, S.; Mesclon, F.; Carraro, V.; Parry, L.; Jousse, C.; Bruhat, A.; Maurin, A.; Pierre, P.; Proud, C.; Fafournoux, P.
2011Understanding the mechanism of insulin and insulin-like growth factor (IGF) receptor activation by IGF-IIAlvino, C.; Ong, S.; McNeil, K.; Delaine, C.; Booker, G.; Wallace, J.; Forbes, B.; Wilson, E.
2012Opioid activation of toll-like receptor 4 contributes to drug reinforcementHutchinson, M.; Northcutt, A.; Hiranita, T.; Wang, X.; Lewis, S.; Thomas, J.; van Steeg, K.; Kopajtic, T.; Loram, L.; Sfregola, C.; Galer, E.; Miles, N.; Bland, S.; Amat, J.; Rozeske, R.; Maslanik, T.; Chapman, T.; Strand, K.; Fleshner, M.; Bachtell, R.; et al.
2015Cabozantinib inhibits abiraterone's upregulation of IGFIR phosphorylation and enhances its anti-prostate cancer activityWang, X.; Huang, Y.; Christie, A.; Bowden, M.; Lee, G.; Kantoff, P.; Sweeney, C.

Discover